The Platelet Function Analyzer test, often called the PFA-100 test, checks how quickly platelets form a plug under conditions that imitate fast blood flow through a small injured blood vessel. The result is called closure time. A longer closure time means the platelet plug took longer than expected to block the test opening, which points to a problem with primary hemostasis—the first stage of stopping bleeding. The test is most useful when a person has easy bruising, nosebleeds, heavy menstrual bleeding, bleeding after dental work, suspected von Willebrand disease, possible aspirin effect, or unexplained bleeding with a normal basic coagulation screen. A PFA-100 result does not diagnose one specific disorder by itself. It works best when interpreted with the bleeding history, platelet count, hematocrit, von Willebrand factor tests, medication history, and sometimes platelet aggregation studies.
- A PFA-100 result is reported as closure time in seconds; a prolonged closure time means delayed platelet plug formation.
- Common reference intervals are roughly 90–160 seconds for collagen/epinephrine and 70–124 seconds for collagen/ADP, but each lab must use its own range.
- Aspirin and many NSAIDs usually prolong the collagen/epinephrine result while leaving collagen/ADP normal.
- Prolonged results commonly occur with von Willebrand disease, low platelets, anemia, inherited platelet disorders, kidney failure, and antiplatelet drugs.
- A normal PFA-100 result lowers the chance of some platelet or von Willebrand problems, but it does not rule out mild bleeding disorders.
- Urgent medical care is needed for heavy uncontrolled bleeding, black stools, vomiting blood, sudden severe headache, or bleeding with fainting or shortness of breath.
Table of Contents
- What the PFA-100 Test Measures
- How Closure Time Works
- Normal Range and Result Patterns
- Causes of Prolonged Closure Time
- Bleeding Risk and Clinical Meaning
- Preparation, Sample Handling, and Limitations
- Follow-Up Tests After Abnormal Results
- Practical Questions About PFA-100 Results
What the PFA-100 Test Measures
The PFA-100 test measures how well platelets, von Willebrand factor, and the blood sample as a whole form a primary platelet plug. This first plug forms before the stronger fibrin clot develops. It is especially important in small blood vessels, where bleeding often shows up as easy bruising, nosebleeds, gum bleeding, heavy periods, or prolonged bleeding after minor cuts.
Platelets are small blood cell fragments that stick to the damaged blood vessel wall, activate, release chemical signals, and clump together. Von Willebrand factor acts like a bridge between platelets and exposed vessel-wall collagen. Without enough functional von Willebrand factor, platelets have trouble sticking firmly under high blood-flow conditions.
The PFA-100 does not count platelets. It tests platelet function in a citrated whole-blood sample. A person can have a normal platelet count but abnormal platelet function, especially after aspirin use or in certain inherited platelet disorders.
The test is often ordered when the bleeding pattern suggests a primary hemostasis problem rather than a clotting factor problem. Clotting factor problems more often prolong PT, INR, or aPTT and are evaluated with tests such as a coagulation panel. In real practice, both pathways often need review because bleeding symptoms overlap.
The PFA-100 is mainly a screening and pattern-recognition test. It helps answer questions such as:
- Is there evidence of impaired platelet plug formation?
- Is the pattern compatible with aspirin or NSAID effect?
- Does the result support further testing for von Willebrand disease?
- Is a low platelet count or anemia interfering with primary hemostasis?
- Does the bleeding history justify more specialized platelet testing?
It does not answer every platelet question. It does not identify the exact platelet defect, prove that a person will bleed during surgery, or replace a careful bleeding history.
How Closure Time Works
The PFA-100 draws citrated whole blood through a tiny opening in a membrane coated with collagen plus another platelet activator. The two main cartridges are collagen/epinephrine and collagen/ADP. As blood passes through the opening under high shear stress, platelets stick, activate, and build a plug. The instrument records the time needed to block the opening. This time is the closure time.
A shorter closure time means the opening closed quickly. A longer closure time means the platelet plug formed slowly or did not close the aperture within the instrument’s measurement limit.
Collagen/epinephrine cartridge
The collagen/epinephrine cartridge is sensitive to aspirin-like platelet inhibition. Aspirin blocks platelet cyclooxygenase-1, reducing thromboxane A2, a signal that helps platelets activate and recruit other platelets. Because of this, aspirin commonly prolongs collagen/epinephrine closure time.
A typical aspirin pattern is:
- Collagen/epinephrine prolonged
- Collagen/ADP normal or near normal
This pattern also occurs with some nonsteroidal anti-inflammatory drugs, although the effect from many NSAIDs is temporary and fades as the drug clears.
Collagen/ADP cartridge
The collagen/ADP cartridge is less sensitive to aspirin. When both collagen/epinephrine and collagen/ADP are prolonged, the result suggests a broader primary hemostasis problem. Common possibilities include von Willebrand disease, low platelet count, significant anemia, strong platelet dysfunction, or an interfering medication.
A normal collagen/ADP result does not prove platelet function is normal. It only means the test opening closed within the lab’s reference interval using that cartridge.
Why the test uses whole blood
The PFA-100 uses whole blood because platelet plug formation depends on more than platelets alone. Red blood cells push platelets toward the vessel wall during fast flow. Von Willebrand factor helps platelets attach. Platelet count, hematocrit, blood group, sample timing, and medications all affect the result.
This whole-blood design gives the PFA-100 practical value, but it also explains why the test is not specific. A prolonged closure time tells the clinician that primary hemostasis was delayed in the sample. It does not automatically reveal the cause.
Normal Range and Result Patterns
A normal PFA-100 closure time means the platelet plug formed within the lab’s expected time for that cartridge. Reference intervals vary by instrument, cartridge lot, anticoagulant concentration, population, and local validation. Many laboratories report values close to 90–160 seconds for collagen/epinephrine and 70–124 seconds for collagen/ADP, while other validated ranges are wider.
The safest rule is simple: use the reference interval printed on the laboratory report. Do not compare your result with an online range without checking the lab’s method.
| Collagen/epinephrine | Collagen/ADP | Common meaning | Typical next step |
|---|---|---|---|
| Normal | Normal | No major delay detected in this screening test | Review symptoms; further testing if bleeding history is strong |
| Prolonged | Normal | Aspirin or NSAID effect is common | Check medication timing and repeat if needed after medical advice |
| Prolonged | Prolonged | Broader primary hemostasis problem | Check CBC, von Willebrand tests, medication list, and platelet studies |
| Normal | Prolonged | Less common pattern; may reflect sample, lab, or specific platelet issues | Repeat or investigate based on symptoms and lab review |
PFA-100 results are reported in seconds, not as “high” or “low” in the same way as many chemistry blood tests. The main abnormality is prolonged closure time. A very short closure time usually has less established clinical meaning and is not used alone to diagnose a clotting tendency.
Normal result
A normal result is reassuring when the bleeding history is mild and the platelet count, hematocrit, PT, INR, aPTT, and fibrinogen are also normal. It makes severe von Willebrand disease and major platelet plug defects less likely.
A normal result does not rule out mild platelet secretion defects, mild von Willebrand disease, some storage pool disorders, connective tissue-related bruising, local causes of bleeding, or bleeding linked to medications not strongly detected by this assay. A person with convincing symptoms still needs a clinical review, even when the PFA-100 result is normal.
Prolonged result
A prolonged closure time means the sample took longer than expected to form a platelet plug. The most useful question is not “How bad is the number?” but “What pattern and context explain it?”
A mildly prolonged collagen/epinephrine result after ibuprofen has a different meaning from both cartridges being markedly prolonged in someone with lifelong nosebleeds and heavy periods. The report should be interpreted with the timing of medications, platelet count, hematocrit, and von Willebrand factor results.
Causes of Prolonged Closure Time
A prolonged PFA-100 result has several possible causes. The most common are medication effect, von Willebrand disease, low platelet count, anemia, inherited platelet dysfunction, and acquired platelet dysfunction from illness.
Aspirin and NSAIDs
Aspirin commonly prolongs the collagen/epinephrine closure time. Because aspirin irreversibly affects platelets, its effect lasts for the life of the exposed platelet, often several days. New platelets gradually enter circulation, so platelet function improves as the body replaces affected platelets.
Many NSAIDs, such as ibuprofen and naproxen, also affect platelet function, but their effect is usually reversible and shorter-lived than aspirin. The exact timing depends on the drug, dose, kidney function, and how often it was taken.
Never stop aspirin prescribed for heart attack, stroke, stent, or high cardiovascular risk without medical instruction. For some people, stopping aspirin creates more danger than an abnormal platelet function screen.
Von Willebrand disease
Von Willebrand disease is one of the classic reasons for prolonged PFA-100 closure time. It causes reduced or abnormal von Willebrand factor, which weakens platelet adhesion under high shear flow. People often have nosebleeds, easy bruising, heavy menstrual bleeding, prolonged bleeding after dental work, or bleeding after surgery.
A prolonged PFA-100 result can support the need for a von Willebrand disease panel, but it does not diagnose the condition. Specific testing usually includes von Willebrand factor antigen, von Willebrand factor activity, factor VIII activity, and sometimes multimer analysis or specialized subtype testing.
Blood group affects von Willebrand factor levels. People with blood group O tend to have lower average von Willebrand factor levels than people with non-O blood groups, which can influence closure time. Stress, inflammation, pregnancy, exercise, estrogen therapy, and acute illness can raise von Willebrand factor levels and make borderline disease harder to detect.
Low platelet count or anemia
The PFA-100 result depends on enough platelets and enough red blood cells in the sample. Low platelets can prolong closure time because fewer platelets are available to form the plug. Significant anemia can prolong closure time because red blood cells help move platelets toward the vessel wall under flow.
This is why a CBC matters. A prolonged closure time in someone with thrombocytopenia should not be treated as a pure platelet function disorder until the low count is addressed. When platelets are low, the related question is often covered by a low platelet count evaluation.
Inherited platelet function disorders
Some inherited platelet disorders affect platelet adhesion, activation, secretion, or aggregation. Examples include Glanzmann thrombasthenia, Bernard-Soulier syndrome, platelet storage pool disorders, and secretion defects. The PFA-100 detects some of these problems better than others.
A normal PFA-100 result does not exclude every inherited platelet disorder. Some secretion defects produce normal or inconsistent closure times. When the bleeding history is strong, a platelet aggregation test gives more detailed information about how platelets respond to different activators.
Acquired illness and systemic conditions
Several acquired conditions can impair platelet function. Kidney failure can cause uremic platelet dysfunction. Liver disease can affect platelets, clotting factors, fibrinogen, and bleeding risk in complex ways. Myeloproliferative disorders, myelodysplastic syndromes, severe inflammation, and some autoimmune conditions can also alter platelet behavior.
Medications beyond aspirin matter too. Antiplatelet drugs, some antidepressants, certain antibiotics, valproic acid, high-dose fish oil, and other agents can contribute in selected cases. The medication list should include prescription drugs, over-the-counter pain relievers, supplements, and recent herbal products.
Bleeding Risk and Clinical Meaning
The PFA-100 test helps evaluate bleeding risk, but it does not predict bleeding on its own. Bleeding risk comes from the person, not from one number. The most important clues are the bleeding history, the type of planned procedure, the platelet count, anemia status, von Willebrand factor level, coagulation tests, medications, kidney and liver function, and previous surgical or dental bleeding.
A person with a prolonged closure time but no bleeding history may have a medication effect, borderline lab variation, or a sample issue. A person with a normal closure time but repeated heavy bleeding after dental extraction still needs more evaluation.
Bleeding symptoms that fit platelet-type problems
Platelet and von Willebrand problems often cause mucocutaneous bleeding. That means bleeding from skin and mucous membranes rather than deep tissue.
Common symptoms include:
- Frequent or prolonged nosebleeds
- Gum bleeding not explained by dental disease
- Easy bruising, especially large bruises after minor bumps
- Heavy menstrual bleeding or flooding
- Prolonged bleeding after tooth extraction
- Bleeding after tonsil surgery, childbirth, or minor procedures
- Small red or purple pinpoint spots called petechiae
- Prolonged oozing from cuts
Deep muscle bleeds and spontaneous joint bleeds are more typical of severe clotting factor deficiencies than platelet function disorders, although real patients do not always follow textbook patterns.
Use before surgery or procedures
Routine PFA-100 screening before surgery is controversial when the person has no bleeding history. An abnormal result does not always predict surgical bleeding, and a normal result does not guarantee safety. The test becomes more useful when a patient reports meaningful bleeding symptoms, has a family history of bleeding, takes antiplatelet medication, or has a condition known to affect platelets.
Before a procedure, the clinician usually wants practical answers:
- Has the person bled excessively with previous surgery, childbirth, dental work, or injuries?
- Are aspirin, NSAIDs, clopidogrel, anticoagulants, or supplements involved?
- Is the platelet count low?
- Is the hematocrit low?
- Are PT, INR, aPTT, fibrinogen, and von Willebrand factor results normal?
- Does the procedure involve a high-bleeding-risk site?
The PFA-100 can contribute to this assessment, but it should not replace it.
When abnormal results need urgent attention
A prolonged PFA-100 result by itself is rarely an emergency. Symptoms decide urgency. Seek urgent care for heavy bleeding that will not stop, vomiting blood, black tarry stools, blood in urine with clots, severe headache with neurological symptoms, fainting, chest pain, shortness of breath, or bleeding after head injury.
People taking blood thinners or antiplatelet drugs need lower thresholds for medical advice, especially after trauma or when bleeding is persistent.
Preparation, Sample Handling, and Limitations
Preparation for the PFA-100 test focuses on accurate interpretation. The blood draw is usually similar to other venous blood tests, but the sample must be collected and handled carefully because platelet function changes outside the body.
Tell the clinician and lab about all medications and supplements. This includes aspirin, ibuprofen, naproxen, clopidogrel, prasugrel, ticagrelor, anticoagulants, antidepressants, valproic acid, fish oil, ginkgo, garlic pills, and recent over-the-counter cold or pain products.
Do not stop prescribed antiplatelet or anticoagulant therapy unless the prescribing clinician tells you to. If the goal is to check baseline platelet function, the clinician may schedule testing after a medication washout period. If the goal is to measure medication effect, stopping the drug defeats the purpose.
Sample handling matters
PFA-100 testing uses citrated whole blood, and timing matters. Many laboratories require testing within a defined window after collection, often within a few hours. Samples that are clotted, underfilled, overfilled, hemolyzed, refrigerated incorrectly, shaken hard, or delayed too long can give misleading results.
Platelet tests are more sensitive to pre-analytical problems than many routine chemistry tests. A surprising result sometimes needs repeat testing under controlled conditions before it is treated as a diagnosis.
Major limitations
The PFA-100 has clear limits:
- It is a screening test, not a final diagnosis.
- It is sensitive to platelet count and hematocrit.
- It does not detect every platelet function disorder.
- It does not reliably measure all antiplatelet drugs.
- It is not a stand-alone surgical bleeding predictor.
- It does not explain whether the cause is inherited, acquired, medication-related, or sample-related.
- It cannot replace a detailed bleeding history.
These limits do not make the test useless. They define its proper role. The PFA-100 is most helpful when it guides the next question rather than tries to answer every question.
Follow-Up Tests After Abnormal Results
Follow-up depends on the result pattern and clinical situation. The first step is usually to check whether the abnormal result has an obvious explanation, such as recent aspirin, NSAIDs, low platelet count, low hematocrit, or sample handling problems.
A common follow-up plan includes:
- Review the bleeding history, medication list, and family history.
- Confirm CBC results, especially platelet count and hematocrit.
- Review PT, INR, aPTT, fibrinogen, and sometimes thrombin time if broader clotting concerns exist.
- Order von Willebrand factor testing when symptoms or PFA pattern support it.
- Consider platelet aggregation testing or specialized platelet studies if bleeding remains unexplained.
- Repeat the PFA-100 if the result conflicts with the clinical picture or if medication/sample interference is likely.
A broader platelet function test workup may include light transmission aggregometry, whole-blood impedance aggregometry, flow cytometry, platelet secretion testing, platelet nucleotide studies, or genetic testing. These are specialized tests and often require a hematology laboratory.
Von Willebrand factor tests
When von Willebrand disease is suspected, the PFA-100 result should lead to specific von Willebrand testing rather than a diagnosis by closure time alone. The core tests often include von Willebrand factor antigen, platelet-binding activity, and factor VIII activity. Low antigen means the amount of von Willebrand factor is reduced, which is discussed in more detail under low von Willebrand factor antigen. Low activity means the protein is not working well enough, even if the amount is not severely reduced.
Borderline von Willebrand results often need repeat testing because levels change with stress, inflammation, hormones, pregnancy, exercise, age, and blood group.
Platelet aggregation studies
Platelet aggregation testing is more detailed than PFA-100 screening. It exposes platelet-rich plasma or whole blood to several activators and measures how platelets clump in response. Different response patterns point toward different disorders, such as aspirin effect, ADP receptor pathway problems, Glanzmann thrombasthenia, storage pool deficiency, or secretion defects.
This testing is more technically demanding. It requires fresh samples, careful scheduling, medication review, and experienced interpretation.
Other tests that may matter
The clinician may add kidney function, liver tests, iron studies, inflammatory markers, thyroid tests, or medication levels when the context supports them. For example, kidney failure can impair platelet function even when the platelet count is normal. Iron deficiency anemia can contribute to fatigue and heavy menstrual bleeding while also affecting interpretation of platelet-related testing.
When the bleeding story is strong but standard testing is unrevealing, the diagnosis may be a bleeding disorder of unknown cause. In that setting, normal or borderline PFA-100 results do not end the evaluation.
Practical Questions About PFA-100 Results
Is PFA-100 the same as bleeding time?
No. Bleeding time was an older test that involved making a small standardized skin cut and measuring how long bleeding continued. It had poor reproducibility and caused discomfort and scarring risk. The PFA-100 replaced bleeding time in many settings because it is automated and uses a blood sample, but it still has limitations.
Does a prolonged PFA-100 mean I have a bleeding disorder?
Not always. A prolonged result means platelet plug formation was delayed in the test system. The cause might be aspirin, an NSAID, low platelets, anemia, von Willebrand disease, kidney disease, an inherited platelet disorder, or a sample issue. The result needs a clinical explanation.
Can a normal PFA-100 rule out von Willebrand disease?
A normal result lowers the chance of significant von Willebrand disease, especially when both cartridges are normal and the bleeding history is mild. It does not fully rule out mild type 1 von Willebrand disease or some qualitative forms. Specific von Willebrand factor testing is still needed when symptoms, family history, or procedure-related bleeding raise suspicion.
Can the test show whether aspirin is working?
The collagen/epinephrine cartridge often becomes prolonged after aspirin, so the test can show an aspirin-like effect. It is not the best stand-alone test for aspirin “resistance” or for adjusting antiplatelet therapy. Cardiovascular antiplatelet decisions require a clinician who understands the reason aspirin was prescribed and the person’s clotting and bleeding risks.
What result is considered dangerous?
There is no single closure-time number that automatically means danger. A very prolonged result deserves attention, but symptoms and context matter more. Severe active bleeding, major anemia, very low platelets, or bleeding in a critical site is dangerous regardless of the closure time.
Should the test be repeated?
Repeat testing makes sense when the result was unexpected, the sample may have been delayed or mishandled, the person recently took aspirin or NSAIDs, or the clinician wants to confirm a persistent abnormality. Repeat testing should follow the lab’s handling rules and medication instructions.
How should patients read their report?
Start with four items: closure time in seconds, the lab’s reference interval, the cartridge name, and any comments about sample quality or medication effect. Then compare the pattern with the clinical story. A useful report interpretation might say, “Collagen/epinephrine is prolonged with normal collagen/ADP, a pattern compatible with aspirin or NSAID effect.” A less complete report may only list seconds and flags, so the ordering clinician must interpret it.
References
- Harmonizing platelet function analyzer testing and reporting in a large laboratory network 2022 (Review)
- Establishment of reference intervals for Platelet Function Analyzer -100 closure time in Algerian adults 2021 (Research Article)
- ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease 2021 (Guideline)
- Clinical and laboratory diagnosis of von Willebrand disease 2026 (Review)
- Clinical utility of closure times using the platelet function analyzer-100/200 2017 (Review)
- Point-of-Care Testing in Patients with Hereditary Disorders of Primary Hemostasis: A Narrative Review 2025 (Review)
Disclaimer
This article is educational and does not replace care from a qualified clinician, hematologist, or laboratory medicine specialist. PFA-100 results must be interpreted with symptoms, medication history, CBC results, von Willebrand testing, and other clotting studies. Seek urgent medical care for heavy, persistent, unexplained, or injury-related bleeding.
